CEWE Stiftung & Co. KGaA (FRA:CWC)
Germany · Delayed Price · Currency is EUR 97.90
-2.50 (-2.49%)
Last updated: Aug 1, 2025
Intra-Cellular Therapies Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 845.22 | 837.75 | 784.36 | 735.61 | 694.06 | 728.59 | Upgrade |
Other Revenue | 8.26 | 7.37 | 4.14 | 6.97 | 5.47 | - | Upgrade |
| 853.48 | 845.12 | 788.5 | 742.58 | 699.53 | 728.59 | Upgrade | |
Revenue Growth (YoY) | 6.80% | 7.18% | 6.18% | 6.15% | -3.99% | 0.39% | Upgrade |
Cost of Revenue | 189.67 | 187.85 | 187.15 | 180.59 | 160.44 | 171.48 | Upgrade |
Gross Profit | 663.81 | 657.26 | 601.36 | 561.99 | 539.09 | 557.12 | Upgrade |
Selling, General & Admin | 257.03 | 252.09 | 232.95 | 215.24 | 206.06 | 206.38 | Upgrade |
Other Operating Expenses | 266.73 | 263.18 | 230.71 | 216.88 | 207.98 | 212.88 | Upgrade |
Operating Expenses | 578.38 | 570.01 | 515.49 | 485.2 | 466.33 | 473.98 | Upgrade |
Operating Income | 85.43 | 87.25 | 85.87 | 76.79 | 72.75 | 83.14 | Upgrade |
Interest Expense | -1.72 | -1.62 | -1.95 | -1.54 | -1.51 | -1.48 | Upgrade |
Interest & Investment Income | 1.91 | 2.37 | 5.95 | 0.74 | 2.05 | 0.04 | Upgrade |
Currency Exchange Gain (Loss) | -0.32 | -0.32 | -0.15 | -1.12 | -0.04 | -0.83 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | - | - | -1.88 | Upgrade |
EBT Excluding Unusual Items | 85.31 | 87.68 | 89.72 | 74.87 | 73.25 | 78.98 | Upgrade |
Merger & Restructuring Charges | - | - | - | - | - | -1.17 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | -0.48 | -0.95 | Upgrade |
Asset Writedown | -0.87 | -0.87 | -2 | -0.16 | -0.14 | -0.67 | Upgrade |
Pretax Income | 84.49 | 86.86 | 87.92 | 74.8 | 72.73 | 76.37 | Upgrade |
Income Tax Expense | 25.92 | 26.79 | 28.3 | 23.75 | 23.83 | 24.43 | Upgrade |
Earnings From Continuing Operations | 58.57 | 60.07 | 59.62 | 51.06 | 48.9 | 51.94 | Upgrade |
Earnings From Discontinued Operations | - | - | -2.3 | 0.01 | - | - | Upgrade |
Net Income | 58.57 | 60.07 | 57.31 | 51.07 | 48.9 | 51.94 | Upgrade |
Net Income to Common | 58.57 | 60.07 | 57.31 | 51.07 | 48.9 | 51.94 | Upgrade |
Net Income Growth | -2.09% | 4.81% | 12.23% | 4.43% | -5.85% | 63.83% | Upgrade |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 7 | 7 | Upgrade |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 7 | 7 | Upgrade |
Shares Change (YoY) | -1.82% | -1.66% | -0.37% | -2.29% | 0.17% | -0.09% | Upgrade |
EPS (Basic) | 8.45 | 8.64 | 8.10 | 7.20 | 6.77 | 7.20 | Upgrade |
EPS (Diluted) | 8.44 | 8.63 | 8.10 | 7.19 | 6.72 | 7.15 | Upgrade |
EPS Growth | -0.25% | 6.54% | 12.64% | 7.01% | -6.01% | 63.99% | Upgrade |
Free Cash Flow | - | 75.66 | 77.89 | 38.03 | 27.15 | 103.77 | Upgrade |
Free Cash Flow Per Share | - | 10.87 | 11.00 | 5.35 | 3.73 | 14.29 | Upgrade |
Dividend Per Share | - | 2.850 | 2.600 | 2.450 | 2.350 | 2.300 | Upgrade |
Dividend Growth | - | 9.62% | 6.12% | 4.25% | 2.17% | 15.00% | Upgrade |
Gross Margin | 77.78% | 77.77% | 76.27% | 75.68% | 77.06% | 76.47% | Upgrade |
Operating Margin | 10.01% | 10.32% | 10.89% | 10.34% | 10.40% | 11.41% | Upgrade |
Profit Margin | 6.86% | 7.11% | 7.27% | 6.88% | 6.99% | 7.13% | Upgrade |
Free Cash Flow Margin | - | 8.95% | 9.88% | 5.12% | 3.88% | 14.24% | Upgrade |
EBITDA | 137.08 | 138.05 | 133.31 | 125.47 | 119.84 | 131.46 | Upgrade |
EBITDA Margin | 16.06% | 16.34% | 16.91% | 16.90% | 17.13% | 18.04% | Upgrade |
D&A For EBITDA | 51.64 | 50.8 | 47.44 | 48.68 | 47.09 | 48.33 | Upgrade |
EBIT | 85.43 | 87.25 | 85.87 | 76.79 | 72.75 | 83.14 | Upgrade |
EBIT Margin | 10.01% | 10.32% | 10.89% | 10.34% | 10.40% | 11.41% | Upgrade |
Effective Tax Rate | 30.68% | 30.84% | 32.19% | 31.75% | 32.76% | 31.99% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.